NDAC
This article was originally published in The Tan Sheet
Executive Summary
Committee will meet jointly with Pharmaceutical Science Advisory Committee's Drug Safety & Risk Management Subcommittee April 22, according to tentative advisory committee meeting dates posted on FDA's Web site Feb. 28. Although no agenda has been formally announced, acetaminophen and liver toxicity could be topic for discussion (1"The Tan Sheet" Feb. 18, 2002, p. 3). Additional NDAC meeting dates are April 23, June 21...
You may also be interested in...
Acetaminophen Toxicity Headed To NDAC, New FDA Drug Safety Group
Potential liver toxicity risks from acetaminophen use are likely to be among the topics at the inaugural meeting of FDA's Drug Safety & Risk Management Subcommittee
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.